Drupal.behaviors.print = function(context) {window.print();window.close();}>

Mira Dx Licenses miRNA Technology for Breast Cancer from Yale

February 24, 2011

Mira Dx Licenses miRNA Technology for Breast Cancer from Yale

The technology identifies microRNA disrupting variants in and around the BRCA1 gene that are polymorphic in breast cancer populations.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories